{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T12:05:53Z","timestamp":1779278753056,"version":"3.51.4"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"DOI":"10.1038\/s41390-026-05085-2","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:16:25Z","timestamp":1779275785000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Superior efficacy of CsA plus ATG over CsA monotherapy in pediatric transfusion-independent moderate aplastic anemia"],"prefix":"10.1038","author":[{"given":"Hongmin","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bixi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruixin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"5085_CR1","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s12185-023-03564-4","volume":"119","author":"N Yoshida","year":"2024","unstructured":"Yoshida, N. Recent advances in the diagnosis and treatment of pediatric acquired aplastic anemia. Int. J. Hematol. 119, 240\u2013247 (2024).","journal-title":"Int. J. Hematol."},{"key":"5085_CR2","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s12185-009-0302-9","volume":"89","author":"N Nishio","year":"2009","unstructured":"Nishio, N. et al. Natural history of transfusion-independent non-severe aplastic anemia in children. Int. J. Hematol. 89, 409\u2013413 (2009).","journal-title":"Int. J. Hematol."},{"key":"5085_CR3","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/pbc.20131","volume":"43","author":"SC Howard","year":"2004","unstructured":"Howard, S. C. et al. Natural history of moderate aplastic anemia in children. Pediatr. Blood Cancer 43, 545\u2013551 (2004).","journal-title":"Pediatr. Blood Cancer"},{"key":"5085_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.805197","volume":"9","author":"H Li","year":"2022","unstructured":"Li, H. et al. Cyclosporine monotherapy in pediatric patients with non-severe aplastic anemia: a retrospective analysis. Front. Med. 9, 805197 (2022).","journal-title":"Front. Med."},{"key":"5085_CR5","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1056\/NEJMoa1103975","volume":"365","author":"P Scheinberg","year":"2011","unstructured":"Scheinberg, P. et al. Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. N. Engl. J. Med. 365, 430\u2013438 (2011).","journal-title":"N. Engl. J. Med."},{"key":"5085_CR6","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3324\/haematol.2013.089268","volume":"99","author":"DC Jeong","year":"2014","unstructured":"Jeong, D. C. et al. Long-term outcome after immunosuppressive therapy with horse or rabbit antithymocyte globulin and cyclosporine for severe aplastic anemia in children. Haematologica 99, 664\u2013671 (2014).","journal-title":"Haematologica"},{"key":"5085_CR7","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1182\/blood.V93.7.2191","volume":"93","author":"J Marsh","year":"1999","unstructured":"Marsh, J. et al. Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party. Blood 93, 2191\u20132195 (1999).","journal-title":"Blood"},{"key":"5085_CR8","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1080\/16078454.2021.2009646","volume":"26","author":"XT Zhang","year":"2021","unstructured":"Zhang, X. T. et al. Treatment outcome of 301 aplastic anemia patients in China: a 10-year follow-up and real-world data from single institute experience. Hematology 26, 1025\u20131030 (2021).","journal-title":"Hematology"},{"key":"5085_CR9","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/pbc.24875","volume":"61","author":"DA Williams","year":"2014","unstructured":"Williams, D. A. et al. Diagnosis and treatment of pediatric acquired aplastic anemia (AAA): an initial survey of the North American Pediatric Aplastic Anemia Consortium (NAPAAC). Pediatr. Blood Cancer 61, 869\u2013874 (2014).","journal-title":"Pediatr. Blood Cancer"},{"key":"5085_CR10","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.3324\/haematol.2015.128553","volume":"100","author":"A Hama","year":"2015","unstructured":"Hama, A. et al. Comparison of long-term outcomes between children with aplastic anemia and refractory cytopenia of childhood who received immunosuppressive therapy with antithymocyte globulin and cyclosporine. Haematologica 100, 1426\u20131433 (2015).","journal-title":"Haematologica"},{"key":"5085_CR11","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/bjh.19236","volume":"204","author":"A Kulasekararaj","year":"2024","unstructured":"Kulasekararaj, A. et al. Guidelines for the diagnosis and management of adult aplastic anaemia: a British Society for Haematology Guideline. Br. J. Haematol. 204, 784\u2013804 (2024).","journal-title":"Br. J. Haematol."},{"key":"5085_CR12","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00277-023-05602-x","volume":"103","author":"C Vallejo","year":"2024","unstructured":"Vallejo, C. et al. A multicentre ambispective observational study into the incidence and clinical management of aplastic anaemia in Spain (IMAS study). Ann. Hematol. 103, 705\u2013713 (2024).","journal-title":"Ann. Hematol."},{"key":"5085_CR13","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.3324\/haematol.2017.169862","volume":"102","author":"K Vaht","year":"2017","unstructured":"Vaht, K. et al. Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000-2011. Haematologica 102, 1683\u20131690 (2017).","journal-title":"Haematologica"},{"key":"5085_CR14","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/08880010902771549","volume":"26","author":"S Jiang","year":"2009","unstructured":"Jiang, S. et al. The benefit of ATG in immunosuppressive therapy of children with moderate aplastic anemia. Pediatr. Hematol. Oncol. 26, 313\u2013320 (2009).","journal-title":"Pediatr. Hematol. Oncol."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05085-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05085-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05085-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:16:26Z","timestamp":1779275786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05085-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":14,"alternative-id":["5085"],"URL":"https:\/\/doi.org\/10.1038\/s41390-026-05085-2","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}